Your browser doesn't support javascript.
loading
Fusion events lead to truncation of FOS in epithelioid hemangioma of bone.
van IJzendoorn, David G P; de Jong, Danielle; Romagosa, Cleofe; Picci, Piero; Benassi, Maria Serena; Gambarotti, Marco; Daugaard, Soeren; van de Sande, Michiel; Szuhai, Karoly; Bovée, Judith V M G.
Afiliación
  • van IJzendoorn DG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • de Jong D; Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, The Netherlands.
  • Romagosa C; Department of Pathology, Hospital Vall D'hebron, Barcelona, Spain.
  • Picci P; Laboratory of Experimental Oncology, Orthopaedic Rizzoli Institute, Bologna, Italy.
  • Benassi MS; Laboratory of Experimental Oncology, Orthopaedic Rizzoli Institute, Bologna, Italy.
  • Gambarotti M; Laboratory of Experimental Oncology, Orthopaedic Rizzoli Institute, Bologna, Italy.
  • Daugaard S; Department of Pathology, University of Copenhagen, Denmark.
  • van de Sande M; Department of Orthopedic Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • Szuhai K; Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, The Netherlands.
  • Bovée JV; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Genes Chromosomes Cancer ; 54(9): 565-74, 2015 Sep.
Article en En | MEDLINE | ID: mdl-26173738
ABSTRACT
Epithelioid hemangioma of bone is a locally aggressive vascular neoplasm. It can be challenging to diagnose because of the wide histological spectrum, which can make it difficult to differentiate from other vascular neoplasms such as epithelioid hemangioendothelioma or epithelioid angiosarcoma. COBRA-FISH karyotyping identified a balanced t(3;14) translocation. Transcriptome sequencing of the index case and two other epithelioid hemangiomas revealed a recurrent translocation breakpoint involving the FOS gene, which was fused to different partners in all three cases. The break was observed in exon 4 of the FOS gene and the fusion event led to the introduction of a stop codon. In all instances, the truncation of the FOS gene would result in the loss of the transactivation domain (TAD). Using FISH probes we found a break in the FOS gene in two additional cases, in none of these cases a recurrent fusion partner could be identified. In total, FOS was split in 5/7 evaluable samples. We did not observe point mutations leading to early stop codons in any of the 10 cases where RNA was available. Detection of FOS rearrangement may be a useful diagnostic tool to assist in the often difficult differential diagnosis of vascular tumors of bone. Our data suggest that the translocation causes truncation of the FOS protein, with loss of the TAD, which is thereby a novel mechanism involved in tumorigenesis.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Óseas / Proteínas Oncogénicas v-fos / Fusión Génica / Hemangioma Límite: Adult / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Genes Chromosomes Cancer Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Óseas / Proteínas Oncogénicas v-fos / Fusión Génica / Hemangioma Límite: Adult / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Genes Chromosomes Cancer Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Países Bajos